WebDewpoint Therapeutics is a company developing a platform that provides condensate drug discovery and development services. It offers genetically linked condensatopathy … WebFeb 24, 2024 · Dewpoint Therapeutics co-founder Anthony Hyman will share the 2024 Wiley Prize in Biomedical Sciences for his work on biomolecular condensates. Contacts Rebecca Zacks Dewpoint Therapeutics (617 ...
Dewpoint Therapeutics Appoints Ameet Nathwani as Chief …
WebSep 29, 2024 · BOSTON, Sept. 29, 2024 /PRNewswire/ -- Dewpoint Therapeutics, the biomolecular condensates company, today announced it has raised $77 million in a Series B financing. The round was led by ARCH ... c k purcell plumbing
Dewpoint Therapeutics partners with Novo Nordisk to explore the …
WebEx-VP (HCV Franchise) at Vertex Pharmaceuticals, Ex-Founder and CEO of InnovaTID, and Ex-Founder and CEO at Trek Therapeutics, and Ex … WebExplore {Dewpoint Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Dewpoint Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees WebMar 22, 2024 · Boston, Massachusetts March 22, 2024 – Dewpoint Therapeutics today announced a research and development partnership with Novo Nordisk to identify drug candidates using Dewpoint’s discovery platform related to biomolecular condensates to treat insulin resistance and diabetic complications. ... CEO of Dewpoint Therapeutics. ... ck qdwap